Trajan Group (TRJ) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
10 Jun, 2026Executive summary
FY 2024 revenue was AUD 155 million, within guidance, with underlying/Core nEBITDA of AUD 17.2 million, exceeding the top end of guidance, and consolidated EBITDA more than doubled from H1 to H2.
Net revenue finished within 5% of the prior year, reflecting resilience despite industry-wide destocking in H1 and pharmaceutical sector slowdown in H2; H2 saw a return to growth and improved cost management.
Commercialisation in Disruptive Technologies progressed, with microsampling demand up ~30% in H2 and breakeven nEBITDA targeted for FY25.
Net debt reduced by over AUD 4.7 million, strengthening the balance sheet and returning the net debt to EBITDA ratio to the target range of 2:1.
Statutory EBITDA was impacted by a non-cash impairment of AUD 26.7 million on intangible assets.
Financial highlights
Net revenue for FY24 was AUD 155 million, down 4.4% year-over-year, with declines across all segments; H2 revenue up 2.9% sequentially from H1.
Core/normalized nEBITDA was AUD 17.2 million (FY23: AUD 23.9 million), exceeding guidance.
Pro forma gross margin for FY24 was 41.1%, with H2 margin improving to 42.6%.
Operating NPATA was AUD 0.6 million (FY23: AUD 5.8 million); free cash flow improved to AUD 9.9 million.
Cash balance at June 2024 was AUD 11.2 million; net debt reduced by AUD 4.7 million to AUD 32.9 million.
Outlook and guidance
FY25 revenue expected to exceed AUD 160 million, with group nEBITDA forecasted at AUD 17–19 million, consolidating all segments.
Components & Consumables expected to resume historical growth; Capital Equipment to remain soft in H1 FY25, with recovery anticipated in CY25.
Disruptive Technologies (microsampling) targeted to reach nEBITDA breakeven, with only a AUD 1 million investment/loss projected.
Pro forma gross margin anticipated to return to a growth trend as stocking/destocking cycles subside.
Continued focus on balance sheet strength and launch of Project Neptune Phase 2 for automation and sustainability.
Latest events from Trajan Group
- Record H1 FY25 revenue and EBITDA growth, with guidance and margin improvement maintained.TRJ
H1 202510 Jun 2026 - Record revenue and EBITDA growth, with strong FY26 outlook despite margin and macro pressures.TRJ
H2 202510 Jun 2026 - Revenue up 3.8% to $84.1M; EBITDA down 36.2%; full-year guidance reaffirmed.TRJ
H1 202610 Jun 2026 - All resolutions passed with strong support amid resilient performance and strategic focus.TRJ
AGM 202418 Jan 2026 - Revenue and earnings rose, all resolutions passed, and strategic growth plans advanced.TRJ
AGM 202528 Oct 2025